1. |
Angst BD, Cristiana M. The cadherin superfamily: diversity in form and Function[J]. Cell Sci, 2001,114 (Pt 4): 629-641.
|
2. |
Paco Hulpiaua, Frans van Roy. Molecular evolution of the cadherin superfamily[J]. Int J Biochem Cell Biol, 2009, 41(2): 349-369.
|
3. |
田立立, 王艳丽, 黄韧. 肿瘤转移中E-钙粘蛋白的调控[J]. 中国实验动物学报, 2012, 20(3): 81-85.
|
4. |
朱煊, 彭再如, 刘洋, 等. 前列腺癌组织中E2钙粘蛋白和环氧化酶2表达的研究[J]. 现代泌尿生殖肿瘤杂志, 2009, 1(2): 98-101.
|
5. |
蒋小雷, 卢东, 吴明辉, 等. 膀胱移行细胞癌中S100A4蛋白和钙粘蛋白-E表达及意义[J]. 西部医学, 2012, 24(10): 1863-1866.
|
6. |
Suo L, Lu H, Ying G, et al. Protocadherin clusters and cell adhesion kinase regulate dendrite complexity through Rho GTPase[J]. J Mol Cell Biol, 2012, 4(6): 362-376.
|
7. |
Frank M, Kemler R. Protocadherins[J]. Curr Opin Cell Biol, 2002, 14(5): 557-562.
|
8. |
于钰, 索伦, 吴强. PCDHα在髓鞘形成和少突胶质细胞发育中的作用[J].动物学研究, 2012, 33(4): 362-366.
|
9. |
Hirano K, Kaneko R, Izawa T, et al. Single-neuron diversity generated by Protocadheri-βcluster in mouse central and periphera lnervous systems[J]. Front Mol Neurosci, 2012, 5(90):1-13.
|
10. |
Lin YL, Li ZG, Guan TY. The clinical significance of PCDH10 promoter methylation in patients with bladder transitional cell carcinoma[J]. Urol Int, 2013, 90(2): 219-24.
|
11. |
Ahmed ZM, Riazuddin S, Aye S, et al. Gene structure and mutant alleles of PCDH15: nonsyndromic deafness DFNB23 and type 1 Usher syndrome[J]. Hum Genet, 2008, 124(3): 215-223.
|
12. |
Ahmed ZM, Riazuddin S, Ahmad J, et al. PCDH15 is expressed in the neurosensory epithelium of the eye and ear and mutant alleles are responsible for both USH1F and DFNB23[J]. Hum Mol Genet, 2003, 12(24): 3215-3223.
|
13. |
Rouget-Quermalet V, Giustiniani J, Marie-Cardine A, et al. Protocadherin 15 (PCDH15):a new secreted isoformand a potential marker for NK/T cell lymphomas[J]. Oncogene, 2006, 25(19): 2807-2811.
|
14. |
Mansur IG, Leca G, Pratt JC, et al. Identification of a novel functional 85-kD glycoprotein restricted to long-term dividing human lymphocytic lines[J]. Hum Immunol, 1993, 37(1): 31-38.
|
15. |
Lanier LL.Nk cell recognition[J]. Annu Rev Immunol, 2005, 23: 225-274.
|
16. |
Ham MF, Ko YH. Natural killer cell neoplasm: biology and pathology[J]. Int J Hematol, 2010, 92(5): 681-689.
|
17. |
Seishima M, Yuge M, Kosugi H, et al. Extranodal NK/T-cell Lymphoma, Nasal Type, Possibly Arising from Chronic Epstein-Barr Virus Infection[J]. Acta Derm Venereol, 2010, 90(1): 102-103.
|
18. |
Choi YL, Park JH, Namkung JH, et al. Extranodal NK/T-cell lymphoma with cutaneous involvement: ‘nasal’ vs. ‘nasal-type’ subgroups-a retrospective study of 18 patients[J]. Br J Dermatol, 2009, 160(2): 333-337.
|
19. |
Kim TM, Lee SY, Leon YK, et al. Clinical heterogeneity of extranodal NK/T-cell lymphoma,nasal type: a national survey of the Korean Cancer Study Group[J]. Ann Oncol, 2008, 19(8): 1477-1484.
|
20. |
Pongpruttipan T, Kummalue T, Bedavanija A, et al. Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand[J]. Diagn Pathol, 2011, 6: 79.
|
21. |
Au WY, Pang A, Choy C, et al. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients[J]. Blood, 2004, 104(1): 243-249.
|
22. |
Jaccard A, Nathalie Gachard, Benoit Marin, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone(AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study[J]. Blood, 2012, 117(6): 1834-1839.
|
23. |
Huang JJ, Jiang WQ, Lin TY, et al. Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type[J]. Ann Oncol, 2011, 22(1): 149-155.
|